Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 10, 2019
Albemarle Fine Chemistry Services announced the expansion of its operations at its Tyrone, Pennsylvania custom manufacturing facility.
read more
Friday, November 18, 2022
Albert Labs International Corp. has signed a Letter of Intent (LOI) with full-service Contract-Research Organization (CRO), iNGENu, to carry out the Company's first in-human study of its primary drug target, KRN-101.
read more
Wednesday, February 03, 2016
Eleven Biotherapeutics and Albumedix have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin® albumin variant assets.
read more
Wednesday, December 07, 2016
Albumedix has entered into a collaborative research agreement with the New York University (NYU) School of Medicine. The collaboration will explore the potential of novel applications of Albumedix’s albumin-based drug delivery platform, Veltis®, to ...
read more
Wednesday, February 24, 2016
Albumedix has announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates.
read more
Albumedix announced the CBER has accepted a Drug Master File (DMF) submission for the company’s Recombumin Elite.
read more
Jonas Skjødt Møller is Rosholm’s successor as Chief Executive Officer effective July 1, 2020.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more
Albumedix has announced that its albumin-based VELTIS® half-life extension technology is being used by CSL Behring in IDELVION®, a therapy recently authorized for the treatment of haemophilia B in the U.S.
read more
Capacity expansion at the company’s cGMP manufacturing plant in Nottingham, UK will enable Albumedix to support its next wave of clients from pre-clinical development through to market.
read more
Tuesday, January 20, 2026
Alcami has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of ...
read more
Alcami Corporation has acquired TriPharm Services, a sterile fill-finish manufacturing center located near Research Triangle Park, North Carolina.
read more
Alcami, a provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, and Bruker AXS, a supplier of analytical X-ray solutions, has announced the delivery of Bruker's D8 DISCOVER HTS™ high-throughput...
read more
Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced that its Board of Directors has appointed Timothy Compton as Chief Business Officer. Mr. Compton, who brings over 25-years of industry experience ...
read more
Tuesday, January 14, 2025
Alcami Corporation announced the resignation of Bill Humphries. Alcami’s Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from ...
read more